Lv71
5000 积分 2021-07-13 加入
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
4天前
已完结
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma
4天前
已完结
A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma
5天前
已关闭
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study
5天前
已完结
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab
5天前
已完结
Caffeine and Cardiovascular Health: What the Science Says
10天前
已完结
Early Recanalization After Tenecteplase or Alteplase in Distal and Medium Vessel Occlusion Strokes: An Observational Cohort Study
18天前
已完结
Prospective Observational Cohort Study of Tenecteplase Versus Alteplase in Routine Clinical Practice
18天前
已完结
Tenecteplase Versus Alteplase in Basilar Artery Occlusion Treated with Endovascular Thrombectomy: A Propensity Score–Matched Analysis of 90- and 180-Day Outcomes
18天前
已完结
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial
20天前
已完结
皖公网安备34019202002308
